We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel lead optimization strategy of BACE I inhibitors for the treatment of Alzheimer’s disease by Quantitative Structure-Activity Relationship (QSAR) and Physiologically-Based Pharmacokinetics (PBPK) modeling

Poster   Jan 11, 2017

 
Novel lead optimization strategy of BACE I inhibitors for the treatment of Alzheimer’s disease by Quantitative Structure-Activity Relationship (QSAR) and Physiologically-Based Pharmacokinetics (PBPK) modeling
 
View Poster

Jin-Ju Byeon, Min-Ho Park, Seok-Ho Shin, Young G. Shin

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 
 
 

OTHER POSTERS

2D FT-ICR MS/MS Analysis of lgG1

Poster

Recombinant monoclonal antibodies and derivatives are widely used as therapeutic drugs. This poster explores how you can achieve 2D FT-ICR MS/MS analysis of IgG1.

READ MORE

High Speed Untargeted 4D-lipidomics LC-MS/MS Workflows with PASEF

Poster

Download this poster to discover how PASEF can be used in the search for new and validated biomarkers.

READ MORE

Spontaneous Calcium Oscillations of Networked Human iPSC Derived Cortical Neurons as a Sensitive Model for Neurotoxicity Screening

Poster

BrainXell's human neuron culture platforms provide a means to model the human brain in a dish and perform in vitro functional assays. This system enables the screening of disease phenotypes and pharmacological agents that alter neuronal activity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE